From: Association of serum uric acid levels with COVID-19 severity
 | Model 1 | Model 2 | Model 3 | |
---|---|---|---|---|
β (95% CI) | β (95% CI) | β (95% CI) | ||
UA# | COVID-19 | −0.25†(− 0. 20, − 0.10) | −0.21†(− 0.20, − 0.06) | −0.15†(− 0.17, − 0.01) |
Male | 0.50†(0.22, 0.31) | 0.53†(0.22, 0.33) | 0.47†(0.19, 0.30) | |
COVID-19*Male | – | −0.06 (− 0.15, 0.06) | −0.001 (− 0.10, 0.10) | |
AIC | −79.27 | −78.03 | − 111.46 | |
BIC | −63.68 | −58.54 | − 72.49 | |
UA/Cr ratio# | COVID-19 | −0.21†(− 0.16, − 0.06) | −0.13 (− 0.13, 0.01) | −0.06 (− 0.11, 0.05) |
Male | −0.12†(− 0.10, − 0.01) | −0.07 (− 0.09, 0.02) | −0.08 (− 0.09, − 0.02) | |
COVID-19*Male | – | −0.13 (− 0.20, − 0.01) | −0.11 (− 0.18, 0.02) | |
AIC | −68.02 | −69.28 | −83.80 | |
BIC | − 52.43 | −49.80 | −48.72 |